108 related articles for article (PubMed ID: 23362198)
1. Influence of partial unfolding and aggregation of human stefin B (cystatin B) EPM1 mutants G50E and Q71P on selective cleavages by cathepsins B and S.
Polajnar M; Vidmar R; Vizovišek M; Fonović M; Kopitar-Jerala N; Žerovnik E
Biol Chem; 2013 Jun; 394(6):783-90. PubMed ID: 23362198
[TBL] [Abstract][Full Text] [Related]
2. Gain in toxic function of stefin B EPM1 mutants aggregates: correlation between cell death, aggregate number/size and oxidative stress.
Polajnar M; Zavašnik-Bergant T; Kopitar-Jerala N; Tušek-Žnidarič M; Zerovnik E
Biochim Biophys Acta; 2014 Sep; 1843(9):2089-99. PubMed ID: 24909779
[TBL] [Abstract][Full Text] [Related]
3. Reduced cystatin B activity correlates with enhanced cathepsin activity in progressive myoclonus epilepsy.
Rinne R; Saukko P; Järvinen M; Lehesjoki AE
Ann Med; 2002; 34(5):380-5. PubMed ID: 12452481
[TBL] [Abstract][Full Text] [Related]
4. Cathepsin B but not cathepsins L or S contributes to the pathogenesis of Unverricht-Lundborg progressive myoclonus epilepsy (EPM1).
Houseweart MK; Pennacchio LA; Vilaythong A; Peters C; Noebels JL; Myers RM
J Neurobiol; 2003 Sep; 56(4):315-27. PubMed ID: 12918016
[TBL] [Abstract][Full Text] [Related]
5. Human stefin B normal and patho-physiological role: molecular and cellular aspects of amyloid-type aggregation of certain EPM1 mutants.
Polajnar M; Ceru S; Kopitar-Jerala N; Zerovnik E
Front Mol Neurosci; 2012; 5():88. PubMed ID: 22936898
[TBL] [Abstract][Full Text] [Related]
6. Protein aggregation as a possible cause for pathology in a subset of familial Unverricht-Lundborg disease.
Ceru S; Rabzelj S; Kopitar-Jerala N; Turk V; Zerovnik E
Med Hypotheses; 2005; 64(5):955-9. PubMed ID: 15780491
[TBL] [Abstract][Full Text] [Related]
7. In vitro study of stability and amyloid-fibril formation of two mutants of human stefin B (cystatin B) occurring in patients with EPM1.
Rabzelj S; Turk V; Zerovnik E
Protein Sci; 2005 Oct; 14(10):2713-22. PubMed ID: 16155205
[TBL] [Abstract][Full Text] [Related]
8. Thickened skull, scoliosis and other skeletal findings in Unverricht-Lundborg disease link cystatin B function to bone metabolism.
Suoranta S; Manninen H; Koskenkorva P; Könönen M; Laitinen R; Lehesjoki AE; Kälviäinen R; Vanninen R
Bone; 2012 Dec; 51(6):1016-24. PubMed ID: 23010349
[TBL] [Abstract][Full Text] [Related]
9. Cystatin B: mutation detection, alternative splicing and expression in progressive myclonus epilepsy of Unverricht-Lundborg type (EPM1) patients.
Joensuu T; Kuronen M; Alakurtti K; Tegelberg S; Hakala P; Aalto A; Huopaniemi L; Aula N; Michellucci R; Eriksson K; Lehesjoki AE
Eur J Hum Genet; 2007 Feb; 15(2):185-93. PubMed ID: 17003839
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanism of inhibition of cysteine proteinases by their protein inhibitors: kinetic studies with natural and recombinant variants of cystatins and stefins.
Machleidt W; Thiele U; Assfalg-Machleidt I; Förger D; Auerswald EA
Biomed Biochim Acta; 1991; 50(4-6):613-20. PubMed ID: 1801731
[TBL] [Abstract][Full Text] [Related]
11. Role of the single cysteine residue, Cys 3, of human and bovine cystatin B (stefin B) in the inhibition of cysteine proteinases.
Pol E; Björk I
Protein Sci; 2001 Sep; 10(9):1729-38. PubMed ID: 11514663
[TBL] [Abstract][Full Text] [Related]
12. Importance of the second binding loop and the C-terminal end of cystatin B (stefin B) for inhibition of cysteine proteinases.
Pol E; Björk I
Biochemistry; 1999 Aug; 38(32):10519-26. PubMed ID: 10441148
[TBL] [Abstract][Full Text] [Related]
13. Tissue Levels of Stefin A and Stefin B in Hepatocellular Carcinoma.
Lin YY; Chen ZW; Lin ZP; Lin LB; Yang XM; Xu LY; Xie Q
Anat Rec (Hoboken); 2016 Apr; 299(4):428-38. PubMed ID: 26753874
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of cathepsins B, H, L, D and their endogenous inhibitors stefins A and B in head and neck carcinoma.
Budihna M; Strojan P; Smid L; Skrk J; Vrhovec I; Zupevc A; Rudolf Z; Zargi M; Krasovec M; Svetic B; Kopitar-Jerala N; Kos J
Biol Chem Hoppe Seyler; 1996 Jun; 377(6):385-90. PubMed ID: 8839984
[TBL] [Abstract][Full Text] [Related]
15. Molecular background of EPM1-Unverricht-Lundborg disease.
Joensuu T; Lehesjoki AE; Kopra O
Epilepsia; 2008 Apr; 49(4):557-63. PubMed ID: 18028412
[TBL] [Abstract][Full Text] [Related]
16. Cystatin B and its EPM1 mutants are polymeric and aggregate prone in vivo.
Cipollini E; Riccio M; Di Giaimo R; Dal Piaz F; Pulice G; Catania S; Caldarelli I; Dembic M; Santi S; Melli M
Biochim Biophys Acta; 2008 Feb; 1783(2):312-22. PubMed ID: 17920138
[TBL] [Abstract][Full Text] [Related]
17. Expression of cysteine proteinases cathepsins B and K and of cysteine proteinase inhibitor cystatin C in giant cell tumor of tendon sheath.
Hansen T; Petrow PK; Gaumann A; Keyszer GM; Otto M; Kirkpatrick CJ; Kriegsmann J
Mod Pathol; 2001 Apr; 14(4):318-24. PubMed ID: 11301348
[TBL] [Abstract][Full Text] [Related]
18. Cysteine cathepsins B and L and their inhibitors stefins A and B in carcinoma of the oropharynx: immunohistochemical study.
Strojan P; Oblak I; Gale N; Smid L; Kos J
Histopathology; 2008 Nov; 53(5):612-4. PubMed ID: 18983473
[No Abstract] [Full Text] [Related]
19. Cleavage of the myristoylated alanine-rich C kinase substrate (MARCKS) by cysteine cathepsins in cells and tissues of stefin B-deficient mice.
Kopitar-Jerala N; Turk B
Biol Chem; 2007 Aug; 388(8):847-52. PubMed ID: 17655504
[TBL] [Abstract][Full Text] [Related]
20. Sensitization of stefin B-deficient thymocytes towards staurosporin-induced apoptosis is independent of cysteine cathepsins.
Kopitar-Jerala N; Schweiger A; Myers RM; Turk V; Turk B
FEBS Lett; 2005 Apr; 579(10):2149-55. PubMed ID: 15811333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
